Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用
The R-enantiomer showed only weak hypoglycemic activity. Repaglinide impurity.
參考文獻
Rufer, C., et al.: J. Med. Chem., 22, 750 (1979), Garrino, M., et al.: Diabetologia, 28, 697 (1985), Garrino, M., et al.: Br. J. Pharmacol., 93, 61 (1988), Panten, U., et al.: Biochem. Pharmacol., 38, 1217 (1989), Verspohl, E., et al.: J. Pharm. Pharmacol., 42, 230 (1990),
滬ICP備17019645號
400-821-0725
